Assay for ribosome stimulation of angiogenin nuclease activity
Methods in Enzymology · 2025
DOI: 10.1016/bs.mie.2024.11.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2025. Verfasst von Emily Sholi und 2 weiteren Autor:innen. Beteiligte Einrichtung: RNA Therapeutics Institute, UMass Chan Medical School, Plantation Street, Worcester, MA, United States. Hauptthemen laut MEDLINE: Ribonuclease, Pancreatic, Ribosomes, Enzyme Assays. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, University of Massachusetts Medical School, National Institutes of Health.
Abstract (Originalsprache)
Angiogenin (RNase 5) is an unusual member of the RNase A family with very weak RNase activity and a preference for tRNA. The tRNAs cleaved by angiogenin are thought to have a variety of roles in cellular processes including translation reprogramming, apoptosis, angiogenesis, and neuroprotection. We recently demonstrated that angiogenin is potently activated by the cytoplasmic 80S ribosome. Angiogenin's binding to the ribosome rearranges the C-terminus of the protein, opening the active site for the cleavage of tRNA delivered to the ribosomal A site which angiogenin occupies. Here, we describe the biochemical procedure to test angiogenin's activation by the ribosome using the assay termed the Ribosome Stimulated Angiogenin Nuclease Assay (RiSANA). RiSANA can be used to test the activity of wild-type or mutant angiogenin, or other RNases, against different tRNAs and with different ribosome complexes. For example, given that angiogenin has been implicated in anti-microbial activity, we tested the ability of bacterial 70S ribosomes to stimulate angiogenin activity and found that the E. coli ribosome does not stimulate angiogenin. We also assayed whether angiogenin's closest homolog, RNase 4, could be stimulated by the ribosome, but unlike angiogenin this enzyme was not further activated by the ribosome. The RiSANA assay promises to reveal new aspects of angiogenin mechanism and may aid in the development of new diagnostic tools and therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RNA Therapeutics Institute, UMass Chan Medical School, Plantation Street, Worcester, MA, United States.
- RNA Therapeutics Institute, UMass Chan Medical School, Plantation Street, Worcester, MA, United States. Electronic address: anna.loveland@umassmed.edu.
- RNA Therapeutics Institute, UMass Chan Medical School, Plantation Street, Worcester, MA, United States. Electronic address: andrei.korostelev@umassmed.edu.
Förderung
- NIGMS NIH HHS
- University of Massachusetts Medical School
- National Institutes of Health
Zitieren
APA
Sholi, E., Loveland, A. B., & Korostelev, A. A. (2025). Assay for ribosome stimulation of angiogenin nuclease activity. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2024.11.007
Vancouver
Sholi E, Loveland AB, Korostelev AA. Assay for ribosome stimulation of angiogenin nuclease activity. Methods in Enzymology. 2025. doi:10.1016/bs.mie.2024.11.007
BibTeX
@article{Sholi2025,
author = {Sholi, Emily and Loveland, Anna B and Korostelev, Andrei A},
title = {Assay for ribosome stimulation of angiogenin nuclease activity},
journal = {Methods in Enzymology},
year = {2025},
doi = {10.1016/bs.mie.2024.11.007}
}
EUVIMED